Literature DB >> 6849224

Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response.

S Rich, J Martinez, W Lam, P S Levy, K M Rosen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6849224     DOI: 10.1016/0002-8703(83)90288-0

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  11 in total

Review 1.  The use, and misuse, of exogenous endothelial-derived vasodilators in acute respiratory failure.

Authors:  A T Dinh-Xuan; F Brunet; J F Dhainaut
Journal:  Intensive Care Med       Date:  1997-11       Impact factor: 17.440

2.  Perioperative management of pulmonary hypertension in children with critical heart disease.

Authors:  Ronald A Bronicki
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-10

3.  Vasodilators in pulmonary hypertension.

Authors:  A Peacock
Journal:  Thorax       Date:  1993-12       Impact factor: 9.139

4.  Sublingual isoprenaline in treatment of primary pulmonary hypertension: discussion paper.

Authors:  J F Ackroyd
Journal:  J R Soc Med       Date:  1985-06       Impact factor: 5.344

5.  Diagnosis and management of primary pulmonary hypertension.

Authors:  U Krishnan
Journal:  Indian J Pediatr       Date:  2000-07       Impact factor: 1.967

6.  Treatment of primary pulmonary hypertension intravenous epoprostenol (prostacyclin).

Authors:  D K Jones; T W Higenbottam; J Wallwork
Journal:  Br Heart J       Date:  1987-03

7.  Detrimental effects of verapamil in patients with primary pulmonary hypertension.

Authors:  M Packer; N Medina; M Yushak; I Wiener
Journal:  Br Heart J       Date:  1984-07

8.  Prediction of favourable responses to long term vasodilator treatment of pulmonary hypertension by short term administration of epoprostenol (prostacyclin) or nifedipine.

Authors:  A Rozkovec; J R Stradling; G Shepherd; J MacDermot; C M Oakley; C T Dollery
Journal:  Br Heart J       Date:  1988-06

9.  Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators.

Authors:  C Houde; D J Bohn; R M Freedom; M Rabinovitch
Journal:  Br Heart J       Date:  1993-11

10.  Vasodilator responsiveness in idiopathic pulmonary arterial hypertension: identifying a distinct phenotype with distinct physiology and distinct prognosis.

Authors:  David Langleben; Stylianos Orfanos
Journal:  Pulm Circ       Date:  2017-06-20       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.